Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

NUVA Stock Annual Income Statement. Download in Excel

NuVasive Inc. logo

NuVasive Inc.

Sector: Healthcare   

Industry: Medical Devices

39.75
 
USD
  
0.00
  
(0.00%)
Previous close: 39.75  Open: 40.62  Bid:   Ask:
52 week range    
39.51   
   41.00
Mkt Cap: 0 M  Avg Vol (90 Days): 0
Peers   
OFIX / 
ATEC / 
SYK / 
GMED / 
Last updated: Sunday 22nd December 2024

Stock Rankings

21
Quality
How are these ranks calculated?
Search for a stock

Financials

NUVA Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles19 M-14 M-16 M-46 M-52 M-54 M-55 M-55 M-61 M-53 M
Basic EPS total0.18-0.361.360.741.60.241.26-0.72-1.240.78
Basic weighted shares outstanding44461.047 M49 M50 M51 M51 M52 M51 M52 M52 M
Cost of sales-180 M-182 M-194 M-240 M-268 M-311 M-312 M-322 M-322 M-337 M
Depreciation-44 M-52 M-50 M-57 M-69 M-75 M-81 M-86 M-87 M-91 M
Depreciation unreconciled19 M14 M
DepreciationAndAmortization19 M-52 M-50 M-57 M-69 M-75 M-81 M-86 M-87 M-91 M
Diluted EPS total0.17-0.361.260.691.480.241.23-0.72-1.240.76
Diluted weighted shares outstanding46786.047 M52 M54 M55 M52 M53 M51 M52 M57 M
GainOnSaleOfSecurity102000.03 M-1 M
GeneralAndAdministrativeExpense-12 M-11 M-9 M-11 M-13 M-13 M-12 M-17 M-18 M-18 M
Gross operating profit505 M580 M617 M722 M758 M791 M856 M729 M817 M865 M
ImpairmentOfCapitalAssets11 M-7 M-7 M-10 M-11 M-10 M-10 M-12 M-12 M
Income before tax10 M-11 M112 M65 M72 M9 M81 M-48 M-58 M52 M
Income restructuring and M&A-6 M-12 M-38 M-83 M70 M68 M
Income taxes3 M6 M47 M29 M-7 M-4 M15 M-10 M6 M12 M
Interest income755000.0968000.02 M1 M440000.0586000.02 M1 M160000.03 M
InterestExpenseNonOperating27 M28 M29 M41 M38 M38 M39 M70 M21 M17 M
InterestExpenseOperating-11 M-11 M-11 M-5 M
MinorityInterests917000.0776000.01 M2 M2 M4 M
MiscOtherSpecialCharges3 M-2 M425000.0-19 M-2 M-8 M-6 M-17 M-25 M-21 M
Net income from total operations8 M-17 M66 M37 M82 M12 M65 M-37 M-64 M40 M
NetIncomeCommonStockholders8 M-17 M66 M37 M82 M12 M65 M-37 M-64 M40 M
NetIncomeContinuousOperations8 M-17 M66 M37 M82 M12 M65 M-37 M-64 M40 M
NetNonOperatingInterestIncomeExpense-26 M-27 M-27 M-39 M-38 M-37 M-37 M-69 M-21 M-15 M
NonRecurringOperationExpense30 M-42 M-43 M5 M28 M
Operating income33 M60 M97 M80 M116 M82 M123 M38 M-12 M88 M
Operating income before depreciation (EBITDA)104 M88 M214 M226 M252 M196 M276 M213 M121 M225 M
OperatingExpense-472 M-562 M-478 M-598 M-647 M-736 M-733 M-691 M-829 M-777 M
Other income net-3 M4 M-425000.019 M2 M8 M6 M17 M25 M21 M
OtherGandA-12 M-11 M-9 M-11 M-13 M-13 M-12 M-17 M-18 M-18 M
OtherImpairmentOfCapitalAssets-1 M-11 M-900000.0
OtherOperatingExpenses-13000.014 M26 M60 M52 M71 M49 M64 M126 M44 M
OtherWriteOff-1 M-743000.0-196000.0
RentAndLandingFees-12 M-11 M-9 M-11 M-13 M-13 M
Research & development expense32 M38 M36 M48 M50 M62 M72 M80 M93 M99 M
ResearchExpense32 M38 M36 M48 M50 M62 M72 M80 M93 M99 M
RestructringAndMnAIncome-6 M-12 M-38 M-83 M70 M68 M
Revenue per share19 M-28 M-32 M-46 M-52 M-54 M-55 M-56 M-61 M-53 M
SalariesAndWages-33 M-34 M-26 M-16 M-14 M-19 M-24 M-15 M-21 M-24 M
Selling Gen & administrative expense420 M468 M457 M534 M540 M576 M611 M547 M610 M634 M
SellingAndMarketingExpense420 M468 M457 M534 M540 M576 M611 M547 M610 M634 M
SellingExpense420 M468 M457 M534 M540 M576 M611 M547 M610 M634 M
Special income/charges-41 M42 M43 M-4 M-28 M10 M-59 M12 M12 M
Total Income available for interest expense (EBIT)26 M6 M130 M100 M110 M47 M119 M23 M-37 M70 M
Total common shares outstanding92 M96 M99 M101 M103 M103 M104 M51 M52 M52 M
Total net income8 M-17 M66 M37 M82 M12 M65 M-37 M-64 M40 M
Total ordinary shares52 M52 M52 M52 M52 M52 M52 M52 M52 M52 M
Total revenues685 M762 M811 M962 M1,027 M1,102 M1,168 M1,051 M1,139 M1,202 M
TotalExpenses-652 M-744 M-672 M-839 M-915 M-1,048 M-1,045 M-1,012 M-1,151 M-1,114 M
TotalRevenue685 M762 M811 M962 M1,027 M1,102 M1,168 M1,051 M1,139 M1,202 M
WriteDown-292000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University